Tissue banks, transplant programs, and biorepository compliance — built for the chain of custody these programs demand.
Tissue banking spans recovery partners, processing, storage, and distribution — often across organizations, always across years. Donor eligibility files assemble from faxes and portals; processing records live in batch folders; distribution logs are spreadsheets. When a recall or adverse reaction demands the full chain, it is rebuilt by hand from all four.
The regulatory exposure runs both directions: FDA 1271 inspections sample donor files for completeness at the time of release, and AATB assessors trace grafts end to end. Both find the seams.
Part 1271 requires donor eligibility determination — screening and testing documented before release — plus GTP processing controls, environmental monitoring, and tracking from donor to consignee. AATB standards deepen the requirements: qualified personnel, validated processes, controlled documents, and complaint and recall procedures that work. UNOS adds its own data and traceability duties for transplant programs.
Kintavo assembles the chain as work happens: eligibility files that show their completeness, processing under signature, and distribution linked donor-to-consignee for the recall you can then actually run.
An adverse reaction report arrives naming a graft. The quality manager opens the donor record: the linked grafts and their distribution records are attached, storage inventory quarantines from the event, and consignee notifications are tracked to acknowledgment. The FDA report drafts from the record inside the deadline.
Every eligibility element shows present, verified, and by whom — and release is gated on the set. When FDA samples files, completeness is a property the system enforced, not a hope the auditor tests.
"Kintavo is the perfect solution for a regional blood center because it grows with you. We can automate our daily quality control processes, improve efficiency, and reduce costs."